159 related articles for article (PubMed ID: 24500997)
1. How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia.
Parr JR; Andrew MJ; Finnis M; Beeson D; Vincent A; Jayawant S
Arch Dis Child; 2014 Jun; 99(6):539-42. PubMed ID: 24500997
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and genetic subtypes of congenital myasthenic syndromes in the pediatric population of Slovenia.
Troha Gergeli A; Neubauer D; Golli T; Butenko T; Loboda T; Maver A; Osredkar D
Eur J Paediatr Neurol; 2020 May; 26():34-38. PubMed ID: 32070632
[TBL] [Abstract][Full Text] [Related]
3. The clinical and molecular landscape of congenital myasthenic syndromes in Austria: a nationwide study.
Krenn M; Sener M; Rath J; Zulehner G; Keritam O; Wagner M; Laccone F; Iglseder S; Marte S; Baumgartner M; Eisenkölbl A; Liechtenstein C; Rudnik S; Quasthoff S; Grinzinger S; Spenger J; Wortmann SB; Löscher WN; Zimprich F; Kellersmann A; Rappold M; Bernert G; Freilinger M; Cetin H
J Neurol; 2023 Feb; 270(2):909-916. PubMed ID: 36308527
[TBL] [Abstract][Full Text] [Related]
4. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].
Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D;
Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of congenital myasthenic syndromes in Spain.
Natera-de Benito D; Töpf A; Vilchez JJ; González-Quereda L; Domínguez-Carral J; Díaz-Manera J; Ortez C; Bestué M; Gallano P; Dusl M; Abicht A; Müller JS; Senderek J; García-Ribes A; Muelas N; Evangelista T; Azuma Y; McMacken G; Paipa Merchan A; Rodríguez Cruz PM; Camacho A; Jiménez E; Miranda-Herrero MC; Santana-Artiles A; García-Campos O; Dominguez-Rubio R; Olivé M; Colomer J; Beeson D; Lochmüller H; Nascimento A
Neuromuscul Disord; 2017 Dec; 27(12):1087-1098. PubMed ID: 29054425
[TBL] [Abstract][Full Text] [Related]
6. A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome.
Estephan EP; Sobreira CFDR; Dos Santos ACJ; Tomaselli PJ; Marques W; Ortega RPM; Costa MCM; da Silva AMS; Mendonça RH; Caldas VM; Zambon AA; Abath Neto O; Marchiori PE; Heise CO; Reed UC; Azuma Y; Töpf A; Lochmüller H; Zanoteli E
J Neurol; 2018 Mar; 265(3):708-713. PubMed ID: 29383513
[TBL] [Abstract][Full Text] [Related]
7. Late presentations of congenital myasthenic syndromes: How many do we miss?
Garg N; Yiannikas C; Hardy TA; Belaya K; Cheung J; Beeson D; Reddel SW
Muscle Nerve; 2016 Oct; 54(4):721-7. PubMed ID: 26910802
[TBL] [Abstract][Full Text] [Related]
8. Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
Kinali M; Beeson D; Pitt MC; Jungbluth H; Simonds AK; Aloysius A; Cockerill H; Davis T; Palace J; Manzur AY; Jimenez-Mallebrera C; Sewry C; Muntoni F; Robb SA
J Neuroimmunol; 2008 Sep; 201-202():6-12. PubMed ID: 18707767
[TBL] [Abstract][Full Text] [Related]
9. Congenital Myasthenic Syndrome: Spectrum of Mutations in an Indian Cohort.
Selvam P; Arunachal G; Danda S; Chapla A; Sivadasan A; Alexander M; Thomas MM; Thomas NJ
J Clin Neuromuscul Dis; 2018 Sep; 20(1):14-27. PubMed ID: 30124556
[TBL] [Abstract][Full Text] [Related]
10. Congenital myasthenic syndrome: Ten years clinical experience from a quaternary care south-Indian hospital.
Wadwekar V; Nair SS; Tandon V; Kuruvilla A; Nair M
J Clin Neurosci; 2020 Feb; 72():238-243. PubMed ID: 31889643
[TBL] [Abstract][Full Text] [Related]
11. Congenital myasthenic syndrome in a cohort of patients with 'double' seronegative myasthenia gravis.
Lorenzoni PJ; Ducci RD; Arndt RC; Hrysay NMC; Fustes OJH; Töpf A; Lochmüller H; Werneck LC; Kay CSK; Scola RH
Arq Neuropsiquiatr; 2022 Jan; 80(1):69-74. PubMed ID: 34932651
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterisation of congenital myasthenic syndromes in Southern Brazil.
Mihaylova V; Scola RH; Gervini B; Lorenzoni PJ; Kay CK; Werneck LC; Stucka R; Guergueltcheva V; von der Hagen M; Huebner A; Abicht A; Müller JS; Lochmüller H
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):973-7. PubMed ID: 20562457
[TBL] [Abstract][Full Text] [Related]
13. Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome.
Jephson CG; Mills NA; Pitt MC; Beeson D; Aloysius A; Muntoni F; Robb SA; Bailey CM
Int J Pediatr Otorhinolaryngol; 2010 Sep; 74(9):991-4. PubMed ID: 20554332
[TBL] [Abstract][Full Text] [Related]
14. Congenital Myasthenic Syndromes in Turkey: Clinical and Molecular Characterization of 16 Cases With Three Novel Mutations.
Öztürk S; Güleç A; Erdoğan M; Demir M; Canpolat M; Gümüş H; Çağlayan AO; Dündar M; Per H
Pediatr Neurol; 2022 Nov; 136():43-49. PubMed ID: 36099689
[TBL] [Abstract][Full Text] [Related]
15. Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes.
Müller JS; Herczegfalvi A; Vilchez JJ; Colomer J; Bachinski LL; Mihaylova V; Santos M; Schara U; Deschauer M; Shevell M; Poulin C; Dias A; Soudo A; Hietala M; Aärimaa T; Krahe R; Karcagi V; Huebner A; Beeson D; Abicht A; Lochmüller H
Brain; 2007 Jun; 130(Pt 6):1497-506. PubMed ID: 17439981
[TBL] [Abstract][Full Text] [Related]
16. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
Müller JS; Mildner G; Müller-Felber W; Schara U; Krampfl K; Petersen B; Petrova S; Stucka R; Mortier W; Bufler J; Kurlemann G; Huebner A; Merlini L; Lochmüller H; Abicht A
Neurology; 2003 Jun; 60(11):1805-10. PubMed ID: 12796535
[TBL] [Abstract][Full Text] [Related]
17. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A
Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479
[TBL] [Abstract][Full Text] [Related]
18. Congenital myasthenic syndromes in adults: clinical features, diagnosis and long-term prognosis.
Theuriet J; Masingue M; Behin A; Ferreiro A; Bassez G; Jaubert P; Tarabay O; Fer F; Pegat A; Bouhour F; Svahn J; Petiot P; Jomir L; Chauplannaz G; Cornut-Chauvinc C; Manel V; Salort-Campana E; Attarian S; Fortanier E; Verschueren A; Kouton L; Camdessanché JP; Tard C; Magot A; Péréon Y; Noury JB; Minot-Myhie MC; Perie M; Taithe F; Farhat Y; Millet AL; Cintas P; Solé G; Spinazzi M; Esselin F; Renard D; Sacconi S; Ezaru A; Malfatti E; Mallaret M; Magy L; Diab E; Merle P; Michaud M; Fournier M; Pakleza AN; Chanson JB; Lefeuvre C; Laforet P; Richard P; Sternberg D; Villar-Quiles RN; Stojkovic T; Eymard B
Brain; 2024 May; ():. PubMed ID: 38696726
[TBL] [Abstract][Full Text] [Related]
19. Congenital myasthenic syndrome due to mutation in CHRNE gene with clinical worsening and thymic hyperplasia attributed to association with autoimmune-myasthenia gravis.
Santos E; Moreira I; Coutinho E; Gonçalves G; Lopes C; Lopes Lima J; Leite MI
Neuromuscul Disord; 2015 Dec; 25(12):928-31. PubMed ID: 26363966
[TBL] [Abstract][Full Text] [Related]
20. Congenital myasthenic syndrome with novel pathogenic variants in the COLQ gene associated with the presence of antibodies to acetylcholine receptors.
Tay CG; Fong CY; Li L; Ganesan V; Teh CM; Gan CS; Thong MK
J Clin Neurosci; 2020 Feb; 72():468-471. PubMed ID: 31831253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
